Essentia Health   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Duluth MN United States (2004)

Organization Overview

First Clinical Trial
2004
NCT00597701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Essentia Health | Essentia Health Cancer Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Alcoholism (Phase 2)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8